Tocilizumab Ameliorates the Hypoxia in COVID-19 Moderate Patients with Bilateral Pulmonary Lesions: A Randomized, Controlled, Open-Label, Multicenter Trial

Dongsheng Wang(University of Science and Technology of China), Xiaoling Xu(Fujian Agriculture and Forestry University), Haiming Wei(University of Science and Technology of China), Tianjun Yang(University of Science and Technology of China), Daqing Xia(University of Science and Technology of China), Xiaowen Hu(Lanzhou University), Aijun Pan(University of Science and Technology of China), Zhen Peng(Cotton Research Institute), Wei Shi(Anhui Medical University), Yonggang Zhou(University of Science and Technology of China), Wei Li(First Affiliated Hospital of Bengbu Medical College), Min Li(117th Hospital of People's Liberation Army), Yan Ma(Harbin Medical University), Yubei Sun(University of Science and Technology of China), Yang Dongliang(Huazhong University of Science and Technology), Yun Yang(Army Medical University), Xiaoyu Zhu(Jiangsu Hengrui Medicine (China)), Xin Yao(Jiangsu Province Hospital), Jun Chen(Shanghai Public Health Clinical Center), Xiaodong Mei(University of Chinese Academy of Sciences), Mingfeng Han(Chinese Academy of Medical Sciences & Peking Union Medical College), Liangye Sun(Anhui Medical University), Lin Dong(Capital Medical University), Binqing Fu(University of Science and Technology of China), Xiao jing WANG(University of Science and Technology of China), Jumei Wang(University of Science and Technology of China)
SSRN Electronic Journal
January 1, 2020
Cited by 18


Related Papers